Status:
COMPLETED
A Qualitative Study on Patients' (un)Ability and (un)Willingness to Use Telemonitoring in Inflammatory Bowel Diseases
Lead Sponsor:
Franciscus Gasthuis
Collaborating Sponsors:
Jeroen Bosch Ziekenhuis
Conditions:
Telemedicine
Inflammatory Bowel Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Crohn's disease and ulcerative colitis (inflammatory bowel disease, IBD) are chronic intestinal inflammations with considerable impact on quality of life. Due to the chronic nature of the disease and ...
Detailed Description
Introduction: Telemedicine has shown to play a promising role in improving IBD treatment. However, it remains uncertain which patients benefit from telemedicine. A feasibility and development project ...
Eligibility Criteria
Inclusion
- Aged \>18 years
- A confirmed IBD-diagnosis according to current guidelines
- Maintenance therapy with no medication changes in the last three months
- Remission:
- Crohn's disease: Faecal calprotectin (FCP) \< 100 µ g/g and Harvey Bradshaw Index (HBI) \< 5
- Ulcerative Colitis: Faecal calprotectin (FCP) \< 250 µ g/g and Simple Clinical Colitis Activity Index scores (SCCAI) \< 3
Exclusion
- Presence of a stoma
- Presence of an ileo-anal pouch or ileorectal anastomosis
Key Trial Info
Start Date :
February 2 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT06123052
Start Date
February 2 2024
End Date
July 1 2024
Last Update
August 26 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Jeroen Bosch Ziekehuis
's-Hertogenbosch, Netherlands, 5223GZ
2
Franciscus
Rotterdam, Netherlands, 3045PM